Venous Interventions

On this page

Venous Access & Imaging - Gateway Guidance

  • Preferred Access Sites:
    • Internal Jugular Vein (IJV): Right IJV preferred (straighter course to SVC).
    • Femoral Vein: Higher risk of DVT/infection.
    • Subclavian Vein: Higher risk of pneumothorax.
    • Basilic/Cephalic Veins (PICC lines).
  • Techniques:
    • Seldinger technique: Needle → guidewire → dilator → catheter.
    • Ultrasound guidance: Standard of care for IJV access; improves success, ↓ complications.
      • Needle visible as hyperechoic line. IJV Cannulation: Long Axis Ultrasound
  • Imaging Modalities:
    • Duplex Ultrasound: Initial assessment; thrombus detection, vessel patency & diameter.
    • Contrast Venography: Gold standard for detailed venous anatomy, stenosis, occlusion.
      • Digital Subtraction Angiography (DSA) commonly used.

⭐ The most common non-infectious complication of central venous catheterization is catheter-related thrombosis.

  • Pre-procedure: Coagulation profile (INR < 1.5, Platelets > 50,000/μL).

IVC Filters & Thrombolysis - Clot Busters

  • IVC Filters: Prevent Pulmonary Embolism (PE) from Deep Vein Thrombosis (DVT).

    • Indications: Anticoagulation (AC) contraindication/complication/failure; High-risk prophylaxis (e.g., major trauma, surgery); Large free-floating iliofemoral thrombus.
    • Types: Permanent; Retrievable (preferred for transient risk, aim retrieval 29-54 days post-implantation).
    • Placement: Typically infrarenal; Suprarenal for specific cases (e.g., renal vein thrombus, pregnancy).
    • Complications: Access site issues, filter migration/fracture, IVC thrombosis, caval perforation. IVC anomalies and filter placement considerations
  • Thrombolysis (Catheter-Directed - CDT): Rapid clot dissolution in severe DVT/PE.

    • Agents: Alteplase (tPA), Urokinase.
    • Indications: Massive PE with hemodynamic instability; Extensive DVT (e.g., iliofemoral) with severe symptoms or limb threat.
    • Key Contraindications: Active bleeding; recent Cerebrovascular Accident (CVA) (<3 months); major surgery/trauma (<3 weeks); uncontrolled Hypertension (HTN) (>185/110 mmHg).
    • Complications: Bleeding (major risk, esp. intracranial), hematoma, allergic reaction.

⭐ For retrievable IVC filters, the FDA recommends evaluation for removal between 29 and 54 days after implantation, once the risk of PE has passed, to reduce long-term filter-related complications like thrombosis or fracture.

Portal Hypertension Solutions - Pressure Plungers

  • Core Aim: Alleviate high portal pressure ($P_{portal}$) & its sequelae (e.g., variceal bleeds, refractory ascites).

  • TIPS (Transjugular Intrahepatic Portosystemic Shunt): Key "pressure plunger".

    • Mechanism: Creates a direct, low-resistance channel using a stent between the intrahepatic portal vein and a hepatic vein.
    • Access: Transjugular (via internal jugular vein).
    • Primary Indications:
      • Refractory/recurrent variceal hemorrhage.
      • Refractory ascites or hepatic hydrothorax.
    • Therapeutic Goal: Achieve portosystemic gradient (PSG) < 12 mmHg.

      ⭐ A post-TIPS PSG < 12 mmHg is crucial for preventing variceal rebleeding.

    • Major Complications: Hepatic encephalopathy (HE) (up to 30%), shunt dysfunction (stenosis/occlusion).
    • Key Contraindications: Severe right heart failure, severe pulmonary hypertension (mPAP > 45 mmHg), active uncontrolled infection. Coronal CT of patent TIPS stent
  • Procedural Overview & Pressure Dynamics

Dialysis Access & Misc - Flow Fixers

  • Dialysis Access:
    • AV Fistula (AVF): Preferred. Brescia-Cimino (radiocephalic). Maturation: 6-8 wks. 📌 Rule of 6s: Flow >600mL/min, Diameter >6mm, Depth <6mm.
    • AV Graft (AVG): PTFE. Use if veins poor. Higher complications (stenosis, infection).
    • Complications: Stenosis (juxta-anastomotic in AVF; venous outflow in AVG), thrombosis, steal syndrome.
    • Intervention: Angioplasty (PTA), stenting, thrombectomy.
  • SVC Syndrome: Obstruction (malignancy, catheter). Facial/arm swelling, dyspnea. Rx: Stenting, thrombolysis.
  • May-Thurner Syndrome: Lt Common Iliac Vein (CIV) compression by Rt Common Iliac Artery (CIA). Lt leg DVT/swelling. Rx: Stenting.
  • Nutcracker Syndrome: Lt Renal Vein (RV) compression (SMA/Aorta). Hematuria, flank pain. Rx: Stenting. May-Thurner syndrome anatomical illustration

⭐ The most common site of stenosis in an AV fistula is at the venous anastomosis or immediate downstream vein (juxta-anastomotic).

High‑Yield Points - ⚡ Biggest Takeaways

  • IVC filters are crucial for DVT/PE when anticoagulation is contraindicated or fails.
  • Catheter-directed thrombolysis (CDT) is vital for massive PE and extensive DVT like iliofemoral.
  • TIPS creation manages refractory variceal bleeding and ascites due to portal hypertension.
  • Major TIPS complications include hepatic encephalopathy and shunt stenosis/occlusion.
  • EVLA/RFA are first-line treatments for symptomatic superficial venous reflux (varicose veins).
  • Adrenal venous sampling is gold standard to localize aldosterone-producing adenomas in Conn's syndrome (primary hyperaldosteronism).

Practice Questions: Venous Interventions

Test your understanding with these related questions

What is the main contraindication for performing a liver biopsy?

1 of 5

Flashcards: Venous Interventions

1/9

What is the investigation of choice for a cirisoid aneurysm?_____

TAP TO REVEAL ANSWER

What is the investigation of choice for a cirisoid aneurysm?_____

Angiography

browseSpaceflip

Enjoying this lesson?

Get full access to all lessons, practice questions, and more.

Start Your Free Trial